Qun Chen

State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

A Machine Learning Model to Predict Post-Operative Intensive Care Unit Admission in Patients with Cancer Based on Clinical Characteristics and Hematologic Parameters Data.

A Machine Learning Model to Predict Post-Operative Intensive Care Unit Admission in Patients with Cancer Based on Clinical Characteristics and Hematologic Parameters Data.

Journal: Journal of clinical medicine

Published: February 26, 2026

Evaluating the tumor response assessment of modified-RECIST 1.1 in advance non-small cell lung cancer: a post-hoc analysis of 1,147 patients from the EAST-LC trial.

Evaluating the tumor response assessment of modified-RECIST 1.1 in advance non-small cell lung cancer: a post-hoc analysis of 1,147 patients from the EAST-LC trial.

Journal: Translational lung cancer research

Published: September 06, 2024

HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype.

HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype.

Journal: Journal for immunotherapy of cancer

Published: May 27, 2024

Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors.

Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors.

Journal: Annals of medicine

Published: December 08, 2023

Preclinical characterization and phase 1 results of ADG106 in patients with advanced solid tumors and non-Hodgkin's lymphoma.

Preclinical characterization and phase 1 results of ADG106 in patients with advanced solid tumors and non-Hodgkin's lymphoma.

Journal: Cell reports. Medicine

Published: June 29, 2023

The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation.

The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation.

Journal: Cellular & molecular immunology

Published: March 17, 2023

Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC: a drug-drug interaction study.

Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC: a drug-drug interaction study.

Journal: Cancer chemotherapy and pharmacology

Published: March 15, 2023

A Novel Surface Modification on Core-Shell Yellow Particles for Electrophoretic Display.

A Novel Surface Modification on Core-Shell Yellow Particles for Electrophoretic Display.

Journal: Micromachines

Published: February 23, 2023

Preclinical characterization and phase I clinical trial of CT053PTSA targets MET, AXL, and VEGFR2 in patients with advanced solid tumors.

Preclinical characterization and phase I clinical trial of CT053PTSA targets MET, AXL, and VEGFR2 in patients with advanced solid tumors.

Journal: Frontiers in immunology

Published: August 22, 2022

Application of High Potential Electrophoretic Particles Modified with High Ionization Mono Ionic Liquid for Electrophoretic Displays.

Application of High Potential Electrophoretic Particles Modified with High Ionization Mono Ionic Liquid for Electrophoretic Displays.

Journal: Micromachines

Published: June 30, 2022

A Novel Modification of Copper (II) Phthalocyanine Particles towards Electrophoretic Displays.

A Novel Modification of Copper (II) Phthalocyanine Particles towards Electrophoretic Displays.

Journal: Micromachines

Published: May 07, 2022

Undifferentiated destruction of mitochondria by photoacoustic shockwave to overcome chemoresistance and radiation resistance in cancer therapy.

Undifferentiated destruction of mitochondria by photoacoustic shockwave to overcome chemoresistance and radiation resistance in cancer therapy.

Journal: Nanoscale

Published: March 04, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026